These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 21821571)

  • 1. Pharmaceutical companies' variation of drug prices within and among countries can improve long-term social well-being.
    Lichtenberg FR
    Health Aff (Millwood); 2011 Aug; 30(8):1539-44. PubMed ID: 21821571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prices of pharmaceuticals in poor countries are much lower than in wealthy countries.
    Schweitzer SO; Comanor WS
    Health Aff (Millwood); 2011 Aug; 30(8):1553-61. PubMed ID: 21821573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug makers to cut prices for developing countries.
    AIDS Alert; 1998 Aug; 13(8 Suppl):1-2. PubMed ID: 11365655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Setting cost-effectiveness thresholds as a means to achieve appropriate drug prices in rich and poor countries.
    Danzon PM; Towse A; Mulcahy AW
    Health Aff (Millwood); 2011 Aug; 30(8):1529-38. PubMed ID: 21821570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Risk sharing methods in middle income countries].
    Inotai A; Kaló Z
    Acta Pharm Hung; 2012; 82(1):43-52. PubMed ID: 22570986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [An analysis of the pharmaceuticals market in Vietnam].
    Simonet D
    Sante; 2001; 11(3):155-60. PubMed ID: 11641078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The level of income appears to have no consistent bearing on pharmaceutical prices across countries.
    Morel CM; McGuire A; Mossialos E
    Health Aff (Millwood); 2011 Aug; 30(8):1545-52. PubMed ID: 21821572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Price differentiation and transparency in the global pharmaceutical marketplace.
    Ridley DB
    Pharmacoeconomics; 2005; 23(7):651-8. PubMed ID: 15987224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the German reference drug program on ex-factory prices of prescription drugs: a panel data approach.
    Augurzky B; Göhlmann S; Gress S; Wasem J
    Health Econ; 2009 Apr; 18(4):421-36. PubMed ID: 18677725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential pricing of new pharmaceuticals in lower income European countries.
    Kaló Z; Annemans L; Garrison LP
    Expert Rev Pharmacoecon Outcomes Res; 2013 Dec; 13(6):735-41. PubMed ID: 24219049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential pricing for pharmaceuticals: reconciling access, R&D and patents.
    Danzon PM; Towse A
    Int J Health Care Finance Econ; 2003 Sep; 3(3):183-205. PubMed ID: 14625999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of generic drug competition on the price of prescription drugs in Ontario.
    Lexchin J
    CMAJ; 1993 Jan; 148(1):35-8. PubMed ID: 8439888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. European prices of newly launched reimbursable pharmaceuticals--a pilot study.
    Martikainen J; Kivi I; Linnosmaa I
    Health Policy; 2005 Nov; 74(3):235-46. PubMed ID: 16226136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Examining the production costs of antiretroviral drugs.
    Pinheiro E; Vasan A; Kim JY; Lee E; Guimier JM; Perriens J
    AIDS; 2006 Aug; 20(13):1745-52. PubMed ID: 16931939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paying a high price for low costs: why there should be no legal constraints on the profits that can be made on drugs for tropical diseases.
    Sonderholm J
    J Med Ethics; 2009 May; 35(5):315-9. PubMed ID: 19407038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medicine prices in urban Mozambique: a public health and economic study of pharmaceutical markets and price determinants in low-income settings.
    Russo G; McPake B
    Health Policy Plan; 2010 Jan; 25(1):70-84. PubMed ID: 19843636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Market-based licensing for HPV vaccines in developing countries.
    Outterson K; Kesselheim AS
    Health Aff (Millwood); 2008; 27(1):130-9. PubMed ID: 18180488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. International differences in drug prices.
    Wagner JL; McCarthy E
    Annu Rev Public Health; 2004; 25():475-95. PubMed ID: 15015931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Companies reduce prices for HIV drugs in developing countries.
    Gottlieb S
    Bull World Health Organ; 2000; 78(6):862. PubMed ID: 10916926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The increasing necessity for market-based pharmaceutical prices.
    Calfee JE
    Pharmacoeconomics; 2000; 18 Suppl 1():47-57. PubMed ID: 11151309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.